Cytokinetics (CYTK) SEC Filings: History & Chart

Cytokinetics, Incorporated(CYTK)

Biotechnology · South San Francisco, CA

$61.88-0.82 (-1.31%)

Delayed quote: Oct 6, 2026, 11:15 AM EDT

About Cytokinetics, Incorporated

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

South San Francisco, CA

673 employees

www.cytokinetics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert I. Blum

View full financials

Form	Filing Date	Accepted	Document
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 22, 2026	Sep 22, 2026	View filing
4	Sep 15, 2026	Sep 15, 2026	View filing
4	Sep 15, 2026	Sep 15, 2026	View filing
4	Sep 11, 2026	Sep 11, 2026	View filing
4	Sep 8, 2026	Sep 8, 2026	View filing
4	Sep 1, 2026	Sep 1, 2026	View filing
4	Aug 31, 2026	Aug 31, 2026	View filing
4	Aug 31, 2026	Aug 31, 2026	View filing
8-K	Aug 28, 2026	Aug 28, 2026	View filing
4	Aug 18, 2026	Aug 18, 2026	View filing
SC 13G/A	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
4	Aug 10, 2026	Aug 10, 2026	View filing
10-Q	Aug 6, 2026	Aug 6, 2026	View filing
8-K	Aug 6, 2026	Aug 6, 2026	View filing
4	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
4	Jul 23, 2026	Jul 23, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 14, 2026	Jul 14, 2026	View filing
SC 13G/A	Jul 8, 2026	Jul 8, 2026	View filing
4	Jul 7, 2026	Jul 7, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing
4	Jul 2, 2026	Jul 2, 2026	View filing

SEC Filings

Recent Filings